pentobarbital will lower the level or influence of atazanavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Mysterious.
pentobarbital will decrease the extent or influence of levamlodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lessen the extent or effect of pazopanib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
Contraindicated (one)pentobarbital will lessen the extent or influence of naloxegol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Usage of naloxegol with solid CYP3A4 inducers is not really recommended
pentobarbital will reduce the level or outcome of fosamprenavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will lessen the level or influence of clarithromycin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Mysterious.
pentobarbital will minimize the level or outcome of diazepam buccal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Sturdy or moderate CYP3A4 inducers might increase amount of diazepam elimination; for that reason, efficacy of diazepam could possibly be reduced.
pentobarbital will lessen the level or outcome of etravirine by influencing hepatic enzyme CYP2C9/10 metabolism. Use Caution/Watch.
Contraindicated (one)pentobarbital will lessen the level or outcome of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with powerful CYP3A4 inducers may result in lowered serum concentrations and lack of antimalarial efficacy
pentobarbital will lessen the extent or impact of felodipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will lower the extent or result of cannabidiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Consider a rise in more info cannabidiol dosage (determined by medical reaction and tolerability) when coadministered with a powerful CYP3A4 inducer.
pentobarbital will minimize the extent or result of buprenorphine, extended-acting injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Intently. Sufferers who transfer to buprenorphine extended-acting injection from transmucosal buprenorphine coadministered with CYP3A4 inducers need to be monitored to guarantee buprenorphine plasma stages are satisfactory.
pentobarbital will decrease the level or result of nelfinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will minimize the level or effect of tamoxifen by influencing hepatic enzyme CYP2C9/10 metabolism. Use Warning/Keep track of.